Open-and closed-loop multiobjective optimal strategies for HIV therapy using NSGA-II

IEEE Transactions on Biomedical Engineering

Volumn 58, Issue 6, 2011, Pages 1678-1685

  Heris, S Mostapha Kalami ^a   Khaloozadeh, Hamid ^a  

^a K N TOOSI UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Highly active antiretroviral therapy (HAART); human immunodeficiency virus (HIV); Multiobjective optimization; Nondominated Sorting Genetic Algorithm II (NSGA II); optimal control

Indexed keywords

HIGHLY ACTIVE ANTI-RETROVIRAL THERAPIES; HUMAN IMMUNODEFICIENCY VIRUS (HIV); MULTI OBJECTIVE; NON-DOMINATED SORTING GENETIC ALGORITHM - II; OPTIMAL CONTROLS;

CLOSED LOOP CONTROL SYSTEMS; CONTROL; DISEASES; GENETIC ALGORITHMS; GROUND VEHICLE PARTS AND EQUIPMENT; VIRUSES;

MULTIOBJECTIVE OPTIMIZATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ARTICLE; CLOSED LOOP MULTIOBJECTIVE OPTIMAL STRATEGY; COMPARATIVE STUDY; DRUG USE; ECONOMIC ASPECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONDOMINATED SORTING GENETIC ALGORITHM II; OPEN LOOP MULTIOBJECTIVE OPTIMAL STRATEGY; QUALITY CONTROL; STRATEGIC PLANNING; TREATMENT PLANNING;

ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG THERAPY, COMPUTER-ASSISTED; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; STOCHASTIC PROCESSES;

EID: 79956361373     PISSN: 00189294     EISSN: 15582531     Source Type: Journal    
DOI: 10.1109/TBME.2011.2110651     Document Type: Article

References (18)

1. I. Craig and X. Xia, "Can HIV/AIDS be controlled? applying control engineering concepts outside traditional fields," IEEE Control Syst. Mag., vol. 25, no. 1, pp. 80-83, Feb. 2005.
2. D. Wodarz and M. A. Nowak, "Mathematical models of HIV pathogenesis and treatment," Bioessays, vol. 24, pp. 1178-1187, 2002. (Pubitemid 35464947)
3. A.Landi,A.Mazzoldi,C.Andreoni,M. Bianchi, A. Cavallini, M. Laurino, L. Ricotti, R. Iuliano, B. Matteoli, and L. Ceccherini-Nelli, "Modelling and control of HIV dynamics," Comput. Methods Prog. Biomed., vol. 89, pp. 162-168, Feb. 2008.
4. D. Wodarz and M. A. Nowak, "Specific therapy regimes could lead to long-term immunological control of HIV," Proc. Nat. Acad. Sci. U.S.A., vol. 96, pp. 14 464-14 469, 1999.
5. M. A. Nowak and R. May, Virus Dynamics: Mathematical Principles of Immunology and Virology. New York: Oxford Univ. Press, 2001.
6. A. S. Perelson and P. W. Nelson, "Mathematical analysis of HIV-1 dynamics in vivo," SIAM Rev., vol. 41, pp. 3-44, Mar. 1999. (Pubitemid 129723746)
7. B. Adams, H. T. Banks, M. Davidian, Hee-dae Kwon, H. T. Tran, S. N. Wynne, and E. S. Rosenberg, "HIV dynamics: Modeling, data anal ysis, and optimal treatment protocols," J. Comp. App. Math., vol. 184, no. 1, pp. 10-49, 2005. (Pubitemid 41100712)
8. C. Lv and Z. Yuan, "Stability analysis of delay differential equation models of HIV-1 therapy for fighting a virus with another virus," J. Math. Anal. Apps., vol. 352, no. 2, pp. 672-683, 2009.
9. R. Ouifki and G. Witten, "Stability analysis of a model for HIV infection with RTI and three intracellular delays," Biosystems, vol. 95, no. 1, pp. 1-6, 2009.
10. V. Costanza, P. S. Rivadeneira, and F. L. Biafore, C. E. DÁttellis, "A closed-loop approach to antiretroviral therapies for HIV infection," Biomed. Signal Process Control, vol. 4, no. 2, pp. 139-148, 2009.
11. A. Jeffrey, X. Xia, and I. Craig, "When to initiate HIV therapy: A control theoretic approach," IEEE Trans. Biomed. Eng., vol. 50, no. 11, pp. 1213-1220, Nov. 2003. (Pubitemid 37339396)
12. H. Chang and A. Astolfi, "Activation of immune response in disease dynamics via controlled drug scheduling," IEEE Trans. Autom. Sci. Eng., vol. 6, no. 2, pp. 248-255, Apr. 2009.
13. J. H. Ko, W. H. Kim, and C. C. Chung, "Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability," IEEE Trans. Biomed. Eng., vol. 53, no. 3, pp. 380-386, Mar. 2006. (Pubitemid 43288815)
14. G. Pannocchia, M. Laurino, and A. Landi, "A model predictive control strategy toward optimal structured treatment interruptions in anti-HIV therapy," IEEE Trans. Biomed. Eng., vol. 57, no. 5, pp. 1040-1050, May 2010.
15. R. Zurakowski and A. R. Teel, "A model predictive control based scheduling method for HIV therapy," J. Theor. Biol., vol. 238, no. 2, pp. 368-382, 2006. (Pubitemid 41828437)
16. H. Shim, S.-J. Han, C. C. Chung, and S. W. Nam, J. H. Seo, "Optimal scheduling of drug treatment for HIV infection: Continuous dose control and receeding horizon control," Int. J. Control. Autom. Syst., vol. 1, no. 3, pp. 282-288, Sep. 2003.
17. K. Deb, A. Pratap, S. Agarwal, and T. Meyarivan, "A fast and elitist multiobjective genetic algorithm: NSGA-II," IEEE Trans. Evol. Comp., vol. 6, no. 2, pp. 182-197, Apr. 2002. (Pubitemid 34555372)
18. N. Srinivas, K. Deb, "Multi-objective function optimization using non-dominated sorting genetic algorithms," Evol. Comp., vol. 2, no. 3, pp. 221-248, 1995